There is significant interest in the use of mushrooms and/or mushroom extracts as dietary supplements based on theories that they enhance immune function and promote health. To some extent, select mushrooms have been shown to have stimulatory action on immune responsiveness, particularly when studied in vitro. However, despite their widespread use for potential health benefits, there is a surprising paucity of epidemiologic and experimental studies that address the biologic activities of mushrooms after oral administration to animals or humans. There have been a number of studies that have addressed the ability of mushrooms to modulate mononuclear cell activation and the phenotypic expression of cytokines and their cognate receptors. There have also been a number of attempts to determine antitumor activities of mushrooms. Such studies are important because many of the components of mushrooms do potentially have significant biologic activity. All data, however, should be tempered by the Possibility that there are toxic levels of metals, including arsenic, lead, cadmium, and mercury as well as the presence of radioactive contamination with 137Cs. In this review, we will Present the comparative biology with respect to both immunological and antitumor activities of mushroom extracts and also highlight the need for further evidence-based research.
KimHJ, ChangWK, KimMK, LeeSS, ChoiBY. Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer97:531–535, 2002.
3.
GarcĩaMA, AlonsoJ, FernándezMI, MelgarMJ. Lead content in edible wild mushrooms in Northwest Spain as indicator of environmental contamination. Arch Environ Contam Toxicol34:330–335, 1998.
4.
SvobodaL, KalacP.Contamination of two edible agaricus spp. mushrooms growing in a town with cadmium, lead, and mercury. Bull Environ Contam Toxicol 71:123–130, 2003.
5.
TravnikovaIG, ShutovVN, BrukGY, BalonovMI, SkuterudL, StrandP, PogorelyJA, BurkovaTF. Assessment of current exposure levels in different population groups of the Kola Peninsula. J Environ Radioact60:235–248, 2002.
6.
LeeIS, NishikawaA. Polyozellus multiplex, a Korean wild mushroom, as a potent chemopreventive agent against stomach cancer. Life Sci 73:3225–3234, 2003.
7.
FujimiyaY, SuzukiY, OshimanK, KoboriH, MoriguchiK, NakashimaH, MatumotoY, TakaharaS, EbinaT, KatakuraR.Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunol Immunother46:147–159, 1998.
8.
TakakuT, KimuraY, OkudaH.Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr131:1409–1413, 2001.
9.
DelmantoRD, Alves de LimaPL, SuguiMM, da EiraAF, SalvadoriDM, SpeitG, RibeiroLR. Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide. Mutat Res496:15–21, 2001.
10.
BarbisanLF, MiyamotoM, ScolasticiC, SalvadoriDMF, RibeiroLR, EiraAF, de CamargoJLV. Influence of aqueous extract of Agaricus blazei on rat liver toxicity induced by different doses of diethylnitrosamine. J Ethnopharmacol83:25–32, 2002.
11.
BarbisanLF, Spinardi-BarbisanAL, MoreiraEL, SalvadoriDM, RibeiroLR, da EiraAF, de CamargoJL. Agaricus blazei (Himematsutake) does not alter the development of rat diethylnitrosamine-initiated hepatic preneoplastic foci. Cancer Sci94:188–192, 2003.
12.
PinheiroF, FariaRR, de CamargoJLV, Spinardi-BarbisanALT, da EiraAF, BarbisanLF. Chemoprevention of preneoplastic liver foci by dietary mushroom Agaricus blazei Murill in the rat. Food Chem Toxicol41:1543–1550, 2003.
13.
Alves de LimaPL, DelmantoRD, SuguiMM, da EiraAF, SalvadoriDM, SpeitG, RibeiroLR. Letinula edodes (Berk.) Pegler (Shiitake) modulates genotoxic and mutagenic effects induced by alkylating agents in vivo. Mutat Res496:23–32, 2001.
14.
SuguiMM, Alves de LimaPL, DelmantoRD, da EiraAF, SalvadoriDMF, RibeiroLR. Antimutagenic effect of Lentinula edodes (BERK.) Pegler mushroom and possible variation among lineages. Food Chem Toxicol41:555–560, 2003.
15.
ZhangY, MillsGL, NairMG. Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa. J Agric Food Chem50:7581–7585, 2002.
16.
PrescottSM, FitzpatrickFA. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta1470:M69–M78, 2000.
17.
ItohH, ItoH, AmanoH, NodaH.Inhibitory action of a (1→6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill (“himematsutake”) on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol66:265–271, 1994.
18.
MizunoM, MorimotoM, MinatoK, TsuchidaH.Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem62:434–437, 1998.
19.
MizunoM, MinatoK, ItoH, KawadeM, TeraiH, TsuchidaH.Antitumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill. Biochem Mol Biol Int47:707–714, 1999.
20.
SorimachiK, AkimotoK, IkeharaY, InafukuK, OkuboA, YamazakiS.Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Struct Funct26:103–108, 2001.
21.
NgML, YapAT. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J Altern Complement Med8:581–589, 2002.
22.
UkawaY, ItoH, HisamatsuM.Antitumor effects of (1→3)-β-D-glucan and (1→6)-β-D-glucan purified from newly cultivated mushroom, Hatakeshimeji (Lyophyllum decastes Sing.). J Biosci Bioeng90:98–104, 2000.
GaoY, ZhouS, ChenG, DaiX, YeJ.A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. extract (Ganopoly) in patients with advanced cancer. Int J Med Mushrooms4:207–214, 2002.
25.
KodamaN, KomutaK, SakaiN, NanbaH.Effects of D-fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull25:1647–1650, 2002.
26.
KodamaN, KomutaK, NanbaH.Can maitake MD-fraction aid cancer patients?Altern Med Rev7:236–239, 2002.
27.
deVere WhiteRW, HackmanRM, SoaresSE, BeckettLA, SunB.Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology60:640–644, 2002.
28.
YapAT, NgML. An improved method for the isolation of lentinan from shiitake mushroom (Lentinus edodes). Int J Med Mushrooms3:9–19, 2001.
29.
JinM, JeonH, JungHJ, KimB, ShinSS, ChoiJJ, LeeJK, KangCY, KimS.Enhancement of repopulation and hematopoiesis of bone marrow cells in irradiated mice by oral administration of PG101, a water-soluble extract from Lentinus lepideus. Exp Biol Med (Maywood)228:759–766, 2003.
30.
OhnoN, HaradaT, MasuzawaS, MiuraNN, AdachiY, NakajimaM, YadomaeT.Antitumor activity and hematopoietic response of a β-glucan extracted from an edible and medicinal mushroom Sparassis crispa Wulf.: Fr. (Aphyllophoromycedtideae). Int J Med Mushrooms4:13–26, 2002.
31.
HaradaT, MiuraN, AdachiY, NakajimaM, YadomaeT, OhnN.Effect of SCG, 1,3-β-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol Pharm Bull25:931–939, 2002.
32.
SanoM, YoshinoK, MatsuzawaT, IkekawaT.Inhibitory effects of edible higher Basidiomycetes mushroom extracts on mouse type IV allergy. Int J Med Mushrooms4:37–41, 2002.
33.
KimGY, KimSH, HwangSY, KimHY, ParkYM, ParkSK, LeeMK, LeeSH, LeeTH, LeeJD. Oral administration of proteoglycan isolated from Phellinus linteus in the prevention and treatment of collagen-induced arthritis in mice. Biol Pharm Bull26:823–831, 2003.
34.
ShigesueK, KodamaN, NanbaH.Effects of maitake (Grifola frondosa) polysaccharide on collagen-induced arthritis in mice. Jpn J Pharmacol84:293–300, 2000.
35.
KodamaN, YamadaM, NanbaH.Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn J Pharmacol87:327–332, 2001.
36.
KimGY, RohSI, ParkSK, AhnSC, OhYH, LeeJD, ParkYM. Alleviation of experimental septic shock in mice by acidic polysaccharide isolated from the medicinal mushroom Phellinus linteus. Biol Pharm Bull26:1418–1423, 2003.
37.
LiuF, OoiVEC, FungMC. Analysis of immunomodulating cytokine mRNAs in the mouse induced by mushroom polysaccharides. Life Sci64:1005–1011, 1999.
38.
SuzukiY, AdachiY, OhnoN, YadomaeT.Th1/Th2-balancing immunomodulating activity of gel-forming (1→3)-β-glucans from fungi. Biol Pharm Bull24:811–819, 2001.
39.
JeanninP, DelnesteY, Lecoanet-HenchozS, GauchatJF, LifeP, HolmesD, BonnefoyJY. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J Exp Med182:1785–1792, 1995.
40.
PetersonJD, HerzenbergLA, VasquezK, WaltenbaughC.Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response Patterns. Proc Natl Acad Sci U S A95:3071–3076, 1998.
41.
MurataY, ShimamuraT, HamuroJ.The polarization of Th1/Th2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol14:201–212, 2002.
42.
MurataY, OhtekiT, KoyasuS, HamuroJ.IFN-g and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur J Immunol32:2866–2873, 2002.
43.
AdachiY, SuzukiY, JinushiT, YadomaeT, OhnoN.Th1-oriented immunomodulating activity of gel-forming fungal (1–.3)-beta-glucans. Int J Med Mushrooms4:95–109, 2002.
44.
SuzukiT, TsuzukiA, OhnoN, OhshimaY, AdachiY, YadomaeT.Synergistic action of β-glucan and platelets on interleukin-8 production by human peripheral blood leukocytes. Biol Pharm Bull25:140–144, 2002.
45.
MurataY, ShimamuraT, TagamiT, TakatsukiF, HamuroJ.The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol2:673–689, 2002.
46.
MillsCD, KincaidK, AltJM, HeilmanMJ, HillAM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol164:6166–6173, 2000.
47.
InoueA, KodamaN, NanbaH.Effect of maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull25:536–540, 2002.
48.
KodamaN, HaradaN, NanbaH.A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol90:357–360, 2002.
49.
HaradaN, KodamaN, NanbaH.Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett192:181–187, 2003.
50.
Maldonado-LopezR, De SmedtT, MichelP, GodfroidJ, PajakB, HeirmanC, ThielemansK, LeoO, UrbainJ, MoserM.CD8alpha+ and CD8alpha– subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med189:587–592, 1999.
51.
PulendranB, SmithJL, CasparyG, BraselK, PettitD, MaraskovskyE, MaliszewskiCR. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A96:1036–1041, 1999.
52.
KimGY, OhYH, ParkYM. Acidic polysaccharide isolated from Phellinus linteus induces nitric oxide-mediated tumoricidal activity of macrophages through protein tyrosine kinase and protein kinase C. Biochem Biophys Res Commun309:399–407, 2003.
53.
FalchBH, EspevikT, RyanL, StokkeBT. The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation. Carbohydr Res329:587–596, 2000.
54.
ThorntonBP, VetvickaV, PitmanM, GoldmanRC, RossGD. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol156:1235–1246, 1996.
55.
XiaY, VetvickaV, YanJ, HanikyrovaM, MayadasT, RossGD. The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol162:2281–2290, 1999.
56.
VetvickaV, ThorntonBP, WiemanTJ, RossGD. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and β-glucan-primed CR3 (CD11b/CD18). J Immunol159:599–605, 1997.
57.
YanJ, VetvickaV, XiaY, CoxonA, CarrollMC, MayadasTN, RossGD. β-glucan, a “specific” biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J Immunol163:3045–3052, 1999.
58.
MiuraT, MiuraNN, OhnoN, AdachiY, ShimadaS, YadomaeT.Failure in antitumor activity by overdose of an immunomodulating β-glucan preparation, sonifilan. Biol Pharm Bull23:249–253, 2000.
59.
MuellerA, RaptisJ, RicePJ, KalbfieischJH, StoutRD, EnsleyHE, BrowderW, WilliamsDL. The influence of glucan polymer structure and solution conformation on binding to (1→3)-β-D-glucan receptors in a human monocyte-like cell line. Glycobiology10:339–346, 2000.
60.
MichalekM, MelicanD, Brunke-ReeseD, LangevinM, LemeriseK, GalbraithW, PatchenM, MackinW.Activation of rat macrophages by Betafectin® PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3). J Leukoc Biol64:337–344, 1998.
61.
GantnerBN, SimmonsRM, CanaveraSJ, AkiraS, UnderhillDM. Collaborative induction of inflammatory responses by dectin-1 and tolllike receptor 2. J Exp Med197:1107–1117, 2003.
62.
LoweE, RiceP, HaT, LiC, KelleyJ, EnsleyH, Lopez-PerezJ, KalbfleischJ, LowmanD, MarglP, BrowderW, WilliamsD.A (1→3)-β-D-linked heptasaccharide is the unit ligand for glucan pattern recognition receptors on human monocytes. Microbes Infect3:789–797, 2001.
63.
WakshullE, Brunke-ReeseD, LindermuthJ, FisetteL, NathansRS, CrowleyJJ, TuftsJC, ZimmermanJ, MackinW, AdamsDS. PGG-glucan, a soluble β-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: evidence for a glycosphingolipid b-(1,3)-glucan receptor. Immunopharmacology41:89–107, 1999.
64.
BrownGD, TaylorPR, ReidDM, WillmentJA, WilliamsDL, Martinez-PomaresL, WongSY, GordonS.Dectin-1 is a major β-glucan receptor on macrophages. J Exp Med196:407–412, 2002.
65.
BrownGD, GordonS.Immune recognition. A new receptor for β-glucans. Nature413:36–37, 2001.
66.
BrownGD, HerreJ, WilliamsDL, WillmentJA, MarshallAS, GordonS.Dectin-1 mediates the biological effects of β-glucans. J Exp Med197:1119–1124, 2003.
67.
PearsonA, LuxA, KriegerM.Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc Natl Acad Sci U S A92:4056–4060, 1995.
68.
ZimmermanJW, LindermuthJ, FishPA, PalaceGP, StevensonTT, DeMongDE. A novel carbohydrate-glycosphingolipid interaction between a β-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J Biol Chem273:22014–22020, 1998.
69.
CzopJK, AustenKF. A β-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol134:2588–2593, 1985.
70.
SzabóT, KadishJL, CzopJK. Biochemical properties of the ligand-binding 20-kDa subunit of the β-glucan receptors on human mononuclear phagocytes. J Biol Chem270:2145–2151, 1995.
71.
MedzhitovR, JanewayCJr.Innate immune recognition: mechanisms and pathways. Immunol Rev173:89–97, 2000.
72.
UnderhillDM. Toll-like receptors: networking for success. Eur J Immunol33:1767–1775, 2003.
73.
OzinskyA, UnderhillDM, FontenotJD, HajjarAM, SmithKD, WilsonCB, SchroederL, AderemA.The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A97:13766–13771, 2000.
74.
TaylorPR, BrownGD, ReidDM, WillmentJA, Martinez-PomaresL, GordonS, WongSY. The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol169:3876–3882, 2002.
75.
AriizumiK, ShenGL, ShikanoS, XuS, RitterR 3rd, KumamotoT, EdelbaumD, MoritaA, BergstresserPR, TakashimaA.Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem275:20157–20167, 2000.
76.
OkaM, HazamaS, SuzukiM, WangF, WadamoriK, IizukaN, TakedaS, AkitomiY, OhbaY, KajiwaraK, SugaT, SuzukiT. In vitro and in vivo analysis of human leukocyte binding by the antitumor polysaccharide, lentinan. Int J Immunopharmacol 18:211–216, 1996.
77.
WillmentJA, GordonS, BrownGD. Characterization of the human β-glucan receptor and its alternatively spliced isoforms. J Biol Chem276:43818–43823, 2001.
CarioE, BrownD, McKeeM, Lynch-DevaneyK, GerkenG, PodolskyDK. Commensal-associated molecular patterns induce selective tolllike receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol160:165–173, 2002.
80.
RescignoM, UrbanoM, ValzasinaB, FrancoliniM, RottaG, BonasioR, GranucciF, KraehenbuhlJP, Ricciardi-CastagnoliP.Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol2:361–367, 2001.
81.
BattleJ, HaT, LiC, Della BeffaV, RiceP, KalbfleischJ, BrowderW, WilliamsD.Ligand binding to the (1→3)-β-D-glucan receptor stimulates NFkB activation, but not apoptosis in U937 cells. Biochem Biophys Res Commun249:499–504, 1998.
82.
HirataN, TsuzukiA, OhnoN, SaitaM, AdachiY, YadomaeT.Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1→3)-β-D-glucan preparation, sonifilan. Zentralbl Bakteriol288:403–413, 1998.
83.
TsuzukiA, TateishiT, OhnoN, AdachiY, YadomaeT.Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1→3)-β-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice. Biosci Biotechnol Biochem63:104–110, 1999.
84.
KataokaK, MutaT, YamazakiS, TakeshigeK.Activation of macrophages by linear (1→3)-β-D-glucans. Implications for the recognition of fungi by innate immunity. J Biol Chem 277:36825–36831, 2002.
85.
MinatoK, MizunoM, TeraiH, TsuchidaH.Autolysis of lentinan, an antitumor polysaccharide, during storage of Lentinus edodes, shiitake mushroom. J Agric Food Chem47:1530–1532, 1999.
86.
OhnoN, FurukawaM, MiuraNN, AdachiY, MotoiM, YadomaeT.Antitumor β-glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull24:820–828, 2001.
87.
OhnoN, MiuraNN, NakajimaM, YadomaeT.Antitumor 1,3-β-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull23:866–872, 2000.
88.
AjithTA, JanardhananKK. Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk) Pilat. J Ethnopharmacol84:157–162, 2003.
89.
JoseN, AjithTA, JananrdhananKK. Antioxidant, anti-inflammatory, and antitumor activities of culinary-medicinal mushroom Pleurotus pulmonarius (Fr.) Quél. (Agaricomycetideae). Int J Med Mushrooms4:329–335, 2002.
90.
BezivinC, DelcrosJ-G, FortinH, AmorosM, BoustieJ.Toxicity and antitumor activity of a crude extract from Lepista inversa (Scop.: Fr.) Pat. (Agaricomycetideae): A preliminary study. Int J Med Mushrooms5:25–30, 2003.
